Skip to main content
Log in

High-risk screening for lung cancer cost effective in Canada

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 Canadian dollars

Reference

  • Cressman S, et al. The cost-effectiveness of high-risk lung cancer screening and drivers of program efficiency. Journal of Thoracic Oncology : 9 May 2017. Available from: URL: http://doi.org/10.1016/j.jtho.2017.04.021

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

High-risk screening for lung cancer cost effective in Canada. PharmacoEcon Outcomes News 779, 20 (2017). https://doi.org/10.1007/s40274-017-4035-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4035-3

Navigation